Long-term outcome of the Milano-HART strategy for high-risk medulloblastoma, including the impact of molecular subtype

CONCLUSIONS: This strategy, partly adopted in the ongoing SIOPE protocol,confirmed improved EFS and OS over previously reported outcomes in all high-risk categories;SHH tumors appeared the most …